MENU
HUMA
AS OF
Dec 12 closing price
Price
$1.31
Change
-$0.00 (-0.00%)
Capitalization
245.33M
103 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
HUMA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Humacyte (HUMA) Ownership - Who owns Humacyte?

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2525 East North Carolina Highway 54
Phone
+1 919 313-9633
Employees
185
Web
https://www.humacyte.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
245.33M
P/E Ratio
N/A
Total Cash
19.49M
Projected Growth
N/A
Total Debt
29.83M
Revenue
1.57M
Risk (Beta)
3.11
Dividend Yield
N/A
Total Cash/Share
0.10
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

HUMA
Capitalization
245M
P/E Ratio
N/A
Risk (Beta)
3.11
Dividend Yield
N/A
Total Cash
19.5M
Total Cash/Share
0.10
Total Debt
29.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
1.57M
ROE
N/A
Book Value
-4.75M
P/B Ratio
57.80
Cash Flow
N/A
Earnings
-0.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
1.62
Current Revenue Per Employee
3422.73
Dividends Per Share - Security
N/A
EBITDA
-18.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.47
Revenue To Assets
-35.84
Shares Held By Institutions
116M
Shares Outstanding - Current
187M
Total Liabilities
96.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
-74.059
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
HUMA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HUMA showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for HUMA
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2525 East North Carolina Highway 54
Phone
+1 919 313-9633
Employees
185
Web
https://www.humacyte.com